Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ST 1435

Known as: ST-1435 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Because of its unique features, the contraceptive effectiveness and tolerance during breast-feeding of 16-methylene-17 alpha… Expand
Is this relevant?
1992
1992
A new modified subdermal implant releasing the potent progestin ST-1435 was studied in eleven fertile-aged women. These implants… Expand
Is this relevant?
1991
1991
The synthetic progestin ST-1435 was administered transdermally to six healthy women during the late luteal phase. The steroid was… Expand
Is this relevant?
1990
1990
A subcutaneous contraceptive capsule releasing progestin ST-1435 was used by 6 breast-feeding women. One to three paired milk and… Expand
Is this relevant?
1990
1990
Four women used vaginal rings releasing the synthetic progestin ST-1435 and ethinyl estradiol for at least three 21-day cycles… Expand
Is this relevant?
1985
1985
One Silastic capsule of 15 mm, 20 mm or 30 mm length was inserted subcutaneously into the ventral aspect of the left forearm or… Expand
Is this relevant?
1984
1984
Nine healthy, fertile women were treated for six months with subdermal contraceptive implants of two different sizes containing a… Expand
  • table 1
  • table 2
Is this relevant?
1983
1983
The nonprotein bound percentage of ST-1435 was measured by centrifugal ultrafiltration dialysis in undiluted female serum at 37… Expand
  • table I
Is this relevant?
1981
1981
An RIA for a new progestin, ST-1435, was developed. Plasma concentrations of this steroid were measured in three women having… Expand
Is this relevant?
1976
1976
The contraceptive action of silastic implants containing a new progestion ST-1435 was investigated in 285 women of reproductive… Expand
Is this relevant?